190 related articles for article (PubMed ID: 37702196)
1. High-dose rate endorectal brachytherapy for rectal cancer: A state-of-the-art review.
Cheng T; Peng R; Qu A; Wang H
Cancer Sci; 2023 Nov; 114(11):4145-4156. PubMed ID: 37702196
[TBL] [Abstract][Full Text] [Related]
2. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review.
Buckley H; Wilson C; Ajithkumar T
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):111-127. PubMed ID: 28816137
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.
Rijkmans EC; Marijnen CAM; van Triest B; Ketelaars M; Cats A; Inderson A; van den Ende RPJ; Laman MS; Kerkhof EM; Nout RA
Radiother Oncol; 2019 Apr; 133():176-182. PubMed ID: 30935576
[TBL] [Abstract][Full Text] [Related]
4. Is the Pathologic Response of T3 Rectal Cancer to High-Dose-Rate Endorectal Brachytherapy Comparable to External Beam Radiotherapy?
Garfinkle R; Lachance S; Vuong T; Mikhail A; Pelsser V; Gologan A; Morin NA; Vasilevsky CA; Boutros M
Dis Colon Rectum; 2019 Mar; 62(3):294-301. PubMed ID: 30741768
[TBL] [Abstract][Full Text] [Related]
5. CT-based adaptive high-dose-rate endorectal brachytherapy in the preoperative treatment of locally advanced rectal cancer: Technical and practical aspects.
Nout RA; Devic S; Niazi T; Wyse J; Boutros M; Pelsser V; Vuong T
Brachytherapy; 2016; 15(4):477-484. PubMed ID: 27090225
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study.
Rijkmans EC; van Triest B; Nout RA; Kerkhof EM; Buijsen J; Rozema T; Franssen JH; Velema LA; Laman MS; Cats A; Marijnen CAM
Radiother Oncol; 2018 Mar; 126(3):417-423. PubMed ID: 29398154
[TBL] [Abstract][Full Text] [Related]
7. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.
Hesselager C; Vuong T; Påhlman L; Richard C; Liberman S; Letellier F; Folkesson J
Colorectal Dis; 2013 Jun; 15(6):662-6. PubMed ID: 23461819
[TBL] [Abstract][Full Text] [Related]
8. Toxicity outcome of endorectal brachytherapy boost in medically inoperable patients.
Chiang CL; Lee SF; Lee VW; Yeung CS; Cheung SK; Poon MC; Foo DC; Lo SH; Lam KO; Lee FA; Wong FC; Chan MK
Strahlenther Onkol; 2020 Nov; 196(11):993-997. PubMed ID: 32313964
[TBL] [Abstract][Full Text] [Related]
9. Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study.
Rijkmans EC; Cats A; Nout RA; van den Bongard DHJG; Ketelaars M; Buijsen J; Rozema T; Franssen JH; Velema LA; van Triest B; Marijnen CAM
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):908-917. PubMed ID: 28366579
[TBL] [Abstract][Full Text] [Related]
10. A systematic review comparing radiation toxicity after various endorectal techniques.
Verrijssen AS; Opbroek T; Bellezzo M; Fonseca GP; Verhaegen F; Gerard JP; Sun Myint A; Van Limbergen EJ; Berbee M
Brachytherapy; 2019; 18(1):71-86.e5. PubMed ID: 30396854
[TBL] [Abstract][Full Text] [Related]
11. Advantages of inflatable multichannel endorectal applicator in the neo-adjuvant treatment of patients with locally advanced rectal cancer with HDR brachytherapy.
Devic S; Vuong T; Moftah B
J Appl Clin Med Phys; 2005; 6(2):44-9. PubMed ID: 15940211
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer.
Vuong T; Devic S
J Contemp Brachytherapy; 2015 Apr; 7(2):183-8. PubMed ID: 26034500
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.
Gerard JP; Barbet N; Schiappa R; Magné N; Martel I; Mineur L; Deberne M; Zilli T; Dhadda A; Myint AS;
Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):356-367. PubMed ID: 36801007
[TBL] [Abstract][Full Text] [Related]
14. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach.
Fleischmann M; Diefenhardt M; Trommel M; Scherf C; Ramm U; Chatzikonstantinou G; Fokas E; Rödel C; Tselis N
Strahlenther Onkol; 2022 Jul; 198(7):654-662. PubMed ID: 35445815
[TBL] [Abstract][Full Text] [Related]
15. Benefit of adaptive CT-based treatment planning in high-dose-rate endorectal brachytherapy for rectal cancer.
van den Ende RPJ; Rijkmans EC; Kerkhof EM; Nout RA; Ketelaars M; Laman MS; Marijnen CAM; van der Heide UA
Brachytherapy; 2018; 17(1):78-85. PubMed ID: 28967560
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate endorectal brachytherapy for locally advanced rectal cancer in previously irradiated patients.
Chuong MD; Fernandez DC; Shridhar R; Hoffe SE; Saini A; Hunt D; Meredith KL; Biagioli MC
Brachytherapy; 2013; 12(5):457-62. PubMed ID: 23707855
[TBL] [Abstract][Full Text] [Related]
17. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects.
Vuong T; Devic S; Moftah B; Evans M; Podgorsak EB
Brachytherapy; 2005; 4(3):230-5. PubMed ID: 16182224
[TBL] [Abstract][Full Text] [Related]
19. Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer.
Garant A; Magnan S; Devic S; Martin AG; Boutros M; Vasilevsky CA; Ferland S; Bujold A; DesGroseilliers S; Sebajang H; Richard C; Vuong T
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1005-1011. PubMed ID: 31476417
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of high dose rate endorectal brachytherapy for patients with rectal cancer.
Vuong T; Garant A; Vendrely V; Martin AG; Devic S
Cancer Radiother; 2022 Oct; 26(6-7):879-883. PubMed ID: 36031497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
